SCHEMBL279202

SCHEMBL279202

C=C(/N=C/c1cc(Br)ccc1Oc1cc(C)nc(C)c1)O[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.36
TSHR P16473 2/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPT P10636 5/20 0.36
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 3/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
AMY1A P0DUB6 1/20 0.34
MEN1 O00255 2/20 0.33
PAX8 Q06710 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL278922 0.86 MAPT (0.32) HPGDMAPT
SCHEMBL279190 0.85 CCR5 (0.43) HPGDTSHRLMNASMN1; SMN2L3MBTL1
SCHEMBL279339 0.84 LMNA (0.40) HPGDTSHRLMNASMN1; SMN2L3MBTL1
SCHEMBL279344 0.81 SLC6A4 (0.46) HPGDTSHRLMNASMN1; SMN2L3MBTL1
SCHEMBL278990 0.81 LMNA (0.39) HPGDTSHRLMNASMN1; SMN2L3MBTL1
SCHEMBL278988 0.80 CCR5 (0.45) HPGDLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL279114 0.79 CCR5 (0.42) HPGDTSHRCCR5
SCHEMBL275218 0.78 HPGD (0.41) HPGDTSHRLMNASMN1; SMN2L3MBTL1
SCHEMBL278924 0.78 LMNA (0.35) HPGDTSHRLMNASMN1; SMN2L3MBTL1
SCHEMBL278945 0.75 HPGD (0.34) HPGDTSHRLMNASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT HPGD 482/4885TSHR 1261/4885LMNA 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.